ARYx Therapeutics , Nasdaq: ARYX
Re-engineering commercially successful drugs to eliminate safety issues.
Industry: Health Care
First Day Return: -19.0%
Industry: Health Care
| IPO Data | |
|---|---|
| IPO File Date | 08/30/2007 |
| Offer Price | $10.00 |
| Price Range $14.00 - $16.00 | |
| Offer Shares (mm) | 5.0 |
| Deal Size ($mm) | $50 |
| Lock-Up Date | IPO Pro Only |
| Street Research | IPO Pro Only |
| IPO Data | |
|---|---|
| IPO Date | 11/06/2007 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $50 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Fremont, CA, United States |
| Founded | 2004 |
| Employees at IPO | 70 |
| Website www.aryx.com | |
ARYx Therapeutics (ARYX) Performance
